Sign in
4

Changes in Ownership

ASCENTAGE PHARMA GROUP INTERNATIONAL Filed Acc 0001213900-26-046036

Options or other derivatives

  • Chief Financial Officer acquired 18,584 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Misra Veet · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-20 Grant or award : show line 1 in the form Restricted stock units +18,584 18,584 D
Loading xslF345X06/marketforms-72968.xml…